FrancophonIA/ELRC3.0 huggingface dataset:
English: Rheumocam 20 mg/ml solution for injection for cattle, pigs and horses Meloxicam
Croatian: Rheumocam 20 mg/ml otopina za injekcije za goveda, svinje i konje Meloksikam
English: Saccharin sodium Carmellose sodium Silica, colloidal anhydrous Citric acid monohydrate Sorbitol, liquid (non-crystallising) Disodium phosphate dodecahydrate Sodium benzoate
Croatian: - natrijev saharin - karmeloza natrij - silika, koloidna bezvodna - limunska kiselina monohidrat - sorbitol, tekući - natrijev dihidrogenfosfat dihidrat - natrijev benzoat - aroma meda - voda, pročišćena
English: Active substance: Meloxicam 15 mg
Croatian: Djelatna tvar: Meloksikam 15 mg
English: {Carton for 100 ml or 250 ml bottle}
Croatian: Kartonska kutija za bočicu od 100 ml ili 250 ml
English: PACKAGE LEAFLET: Rheumocam 0.5 mg/ml oral suspension for cats
Croatian: UPUTA O VMP: Rheumocam 0,5 mg/ml peroralna suspenzija za mačke
English: Rheumocam 0.5 mg/ml oral suspension for cats meloxicam
Croatian: Rheumocam 0,5 mg/ml peroralna suspenzija za mačke meloksikam
English: Ethanol (96%)
Croatian: Pomoćne tvari: Etanol (96%)
English: Shelf life after first opening of the container: 3 months.
Croatian: Rok valjanosti poslije prvog otvaranja spremnika: 3 mjeseca.
English: People with known hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) should avoid contact with the veterinary medicinal product.
Croatian: Osobe preosjetljive na nesteroidne protuupalne lijekove (NSPUL) trebaju izbjegavati doticaj s ovim veterinarsko-medicinskim proizvodom.
English: Λεωθ.
Croatian: Λεωφ.
English: Carton box containing 1 colourless glass injection vial of 20 ml, 50 ml or 100 ml, closed with a bromobutyl rubber stopper and sealed with an aluminium cap.
Croatian: Kartonska kutija koja sadrži 1 ili 12 bezbojnih staklenih injekcijskih bočica od 20 ml, 50 ml ili 100 ml, zatvorenih gumenim čepom i osiguranih aluminijskom kapicom.
English: In very rare cases, haemorrhagic diarrhoea, haematemesis, and gastrointestinal ulceration have been reported.These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment, but in very rare cases may be serious or fatal.
Croatian: U pasa, te se nuspojave obično javljaju tijekom prvog tjedna liječenja i u većini su slučajeva prolazne te nestaju nakon prestanka liječenja, ali u vrlo rijetkim slučajevima mogu biti ozbiljne ili smrtonosne.
English: PACKAGE LEAFLET: Rheumocam 15 mg/ml oral suspension for horses
Croatian: UPUTA O VMP ZA: Rheumocam 15 mg/ml peroralna suspenzija za konje
English: P.B.
Croatian: s.c.
English: PACKAGE LEAFLET: Rheumocam 20 mg/ml solution for injection for cattle, pigs and horses
Croatian: UPUTA O VMP ZA: Rheumocam 20 mg/ml otopina za injekcije za goveda, svinje i konje
English: {Label for 100 ml and 200 ml bottles}
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU {Label for 100 ml and 200 ml bottles}
English: Fatro Ibérica Constitución 1.
Croatian: Fatro Ibérica Constitución 1. P.B. 3 Sant Just Desvern.
English: Rheumocam 5 mg/ml solution for injection for dogs and cats Meloxicam
Croatian: Rheumocam 5 mg/ml otopina za injekcije za pse i mačke Meloksikam
English: Rheumocam 5 mg/ml solution for injection for dogs and cats
Croatian: Rheumocam 5 mg/ml otopina za injekcije za pse i mačke
English: IV injection.
Croatian: i.v. injekcija.
English: Meat and offal: 5 days
Croatian: meso i jestive iznutrice: 5 dana
English: Meloxicam
Croatian: Meloksikam.
English: Do not use this veterinary medicinal product after the expiry date which is stated on the carton and the sachet after EXP.
Croatian: Ne upotrebljavajte nakon isteka roka valjanosti navedenog na kutiji i vrećici iza EXP.
English: PACKAGE LEAFLET: Rheumocam 1.5 mg/ml oral suspension for dogs
Croatian: UPUTA O VMP ZA: Rheumocam 1,5 mg/ml peroralna suspenzija za pse
English: Do not use after the expiry date (EXP) stated on the carton and the bottle.
Croatian: Ne upotrebljavajte nakon isteka roka valjanosti navedenog na kutiji i bočici iza EXP.
English: PACKAGE LEAFLET: Rheumocam 5 mg/ml solution for injection for cattle and pigs
Croatian: UPUTA O VMP Rheumocam 5 mg/ml otopina za injekcije za goveda i svinje
English: Elimination Meloxicam is eliminated with a half-life of 26 hours after subcutaneous injection in young cattle.
Croatian: Nakon supkutane injekcije u mladih goveda, poluživot izlučivanja meloksikama iznosi 26 sati.
English: Meat and offal: 5 days.
Croatian: meso i jestive iznutrice: 5 dana.
English: Shelf life after first opening of the immediate packaging: 3 months.
Croatian: Rok valjanosti poslije prvog otvaranja unutarnjeg pakovanja: 3 mjeseca.
English: PACKAGE LEAFLET: Rheumocam 5 mg/ml solution for injection for dogs and cats
Croatian: UPUTA O VMP ZA: Rheumocam 5 mg/ml otopina za injekcije za pse i mačke
English: Rheumocam 5 mg/ml solution for injection for cattle and pigs Meloxicam
Croatian: Rheumocam 5 mg/ml otopina za injekcije za goveda i svinje Meloksikam
English: Active substance: Meloxicam 1.5 mg.
Croatian: Djelatna tvar: Meloksikam 1,5 mg
English: Therefore the use in horses is not recommended during pregnancy and lactation.
Croatian: Ne primjenjivati u kobila za vrijeme graviditeta ili laktacije.
English: Initial treatment is a single oral dose of 0.2 mg meloxicam/kg body weight (0.4 ml/kg) on the first day.
Croatian: Početak liječenja čini jednokratna peroralna doza od 0,2 mg meloksikama/kg tjelesne mase (0,04 ml /kg) primijenjena prvog dana.
English: Typical adverse reactions of non-steroidal anti-inflammatory drugs (NSAIDs) such as loss of appetite, vomiting, diarrhoea, faecal occult blood, lethargy and renal failure have occasionally been reported.
Croatian: Povremeno su zabilježene nuspojave karakteristične za nesteroidne protuupalne lijekove (NSAID) poput gubitka apetita, povraćanja, proljeva, okultnog krvarenja u izmetu, letargije i zatajenja bubrega.
English: Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg body weight (i.e. 10 ml/100 kg body weight) in combination with antibiotic therapy or with oral re-hydration therapy, as appropriate.
Croatian: Jedna supkutana ili intravenska injekcija u dozi od 0,5 mg meloksikama/kg tjelesne težine (tj. 10,0 ml/100 kg tjelesne težine) u kombinaciji s antibiotskom terapijom ili peroralnom rehidracijskom terapijom, kako je odgovarajuće.
English: Shelf life of the veterinary medicinal product as packaged for sale: 5 years.
Croatian: Rok valjanosti veterinarsko-medicinskog proizvoda kad je zapakiran za prodaju: 5 godine.
English: Cardboard box containing 1 colourless glass injection vial of 20 ml, 50 ml or 100 ml.
Croatian: Kartonska kutija sadrži 1 bezbojnu staklenu bočicu od 20 ml, 50 ml ili 100 ml.
English: Initial treatment is a single oral dose of 0.1 mg meloxicam/kg body weight (0.2 ml/kg) on the first day.
Croatian: Početak liječenja čini jednokratna peroralna doza od 0,1 mg meloksikama/kg tjelesne mase (0,2 ml /kg) primijenjena prvog dana.
English: {Label for 15 ml and 42 ml bottle}
Croatian: OSNOVNI DIJELOVI NAPISANI NA MALIM JEDINICAMA UNUTARNJIH PAKOVANJA {Label for 15 ml and 42 ml bottle}
English: Sodium Carboxyl Methyl Cellulose Colloidal Silicon Dioxide Citric Acid Monohydrate Sorbitol Solution
Croatian: 6.1 Popis pomoćnih tvari natrijev saharin natrij-karboksimetil celuloza silicijev dioksid, koloidni limunska kiselina monohidrat sorbitol, tekući natrijev dihidrogenfosfat dihidrat natrijev benzoat aroma meda
English: Cattle: Meat and offal: 15 days
Croatian: meso i jestive iznutrice: 15 dana
English: Manufacturers responsible for the batch release: Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway,
Croatian: Nositelj odobrenja za proizvodnju odgovoran za puštanje serije u promet: Chanelle Pharmaceuticals Manufacturing Ltd, Loughrea, Co.
English: Do not administer concurrently with glucocorticoids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.
Croatian: Ne primjenjivati istodobno s glukokortikoidima, drugim nesteroidnim protuupalnim lijekovima ili s antikoagulacijskim sredstvima.
English: Typical adverse drug reactions of non-steroidal anti-inflammatory drugs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have occasionally been reported.
Croatian: Povremeno su zabilježene nuspojave karakteristične za nesteroidne protuupalne lijekove (NSPUL) poput gubitka apetita, povraćanja, proljeva, okultnog krvarenja u izmetu, letargije i zatajenja bubrega.
English: Suomi/Finland Orion Pharma Eläinlääkkeet Pl 425, 20101 Turku
Croatian: Suomi/Finland Orion Pharma Eläinlääkkeet
English: Meloxicam 20 mg/ml, Ethanol (96 percent) 159.8 mg/ml.
Croatian: Meloksikam 20 mg/ml Etanol (96%)
English: In case of accidental self-injection, seek medical advice immediately and show this package leaflet or the label to the physician.
Croatian: U slučaju nehotičnog samoinjektiranja, odmah potražiti pomoć liječnika i pokažite mu ovu uputu o VMP ili etiketu.
English: Pregnancy and lactation: Do not use in pregnant or lactating mares.
Croatian: Konji: Ne primjenjivati u kobila za vrijeme graviditeta ili laktacije.
English: - Macrogol 400 - Glycine - Sodium hydroxide - Hydrochloric acid, concentrated - Meglumine - Water for injections.
Croatian: - etanol (96%) - poloksamer 188 - makrogol 400 - glicin - natrijev hidroksid - hidroklorna kiselina - meglumin - voda za injekcije
English: Glycine
Croatian: Galway
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU {Label for 100 ml}
English: Meloxicam: 5 mg/ml Ethanol (96%): 159.8 mg/ml
Croatian: Meloksikam 5 mg/ml Etanol (96%)
English: Each ml contains: 15 mg of meloxicam, 5 mg of sodium benzoate.
Croatian: Meloksikam 15 mg Natrijev benzoat 5 mg
English: {Label for 100 ml vials}
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU {Label for 100 ml vials}
English: For use in the alleviation of inflammation and relief of pain in both acute and chronic musculoskeletal disorders.
Croatian: Za ublažavanje upale i olakšavanje bola u akutnim kroničnim mišićno-koštanim poremećajima.
English: {Label for 20 ml bottles}
Croatian: OSNOVNI DIJELOVI NAPISANI NA MALIM JEDINICAMA UNUTARNJIH PAKOVANJA Label for 20 ml bottles}
English: {Label for 100 ml and 250 ml bottles}
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU {Label for 100 ml and 250 ml bottles}
English: {Carton for 20 ml, 50 ml, 100 ml and 250 ml}
Croatian: Kartonska kutija za bočicu od 20 ml, 50 ml i 100 ml
English: Marketing authorisation holder: Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway, Ireland
Croatian: Nositelj odobrenja za stavljanje u promet: Chanelle Pharmaceuticals Manufacturing Ltd Loughrea, Co.
English: VTN Veterinary and Pharmacy Ltd. PO Box 23886
Croatian: VTN Veterinary and Pharmacy Ltd.
English: 1 pre-filled syringe + 1 injection needle
Croatian: 1 napunjena štrcaljka + 1 injekcijska igla
English: 4 pre-filled syringes + 4 injection needles
Croatian: 4 napunjene štrcaljke + 4 injekcijske igle
English: It is available as tablets (200 mg).
Croatian: Dostupan je u tabletama (200 mg).
English: It must be taken with at least two other antiviral medicines.
Croatian: Mora se uzimati s najmanje dva druga antivirotika.
English: Because the medicine can cause serious rash, treatment starts with 200 mg once a day for two weeks, before increasing the dose to the standard dose of 200 mg twice a day.
Croatian: Budući da lijek može uzrokovati ozbiljan osip, liječenje započinje s 200 mg jednom na dan tijekom dva tjedna, prije nego što se doza poveća na standardnu dozu od 200 mg dva puta na dan.
English: The full EPAR for Nevirapine Teva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za lijek Nevirapine Teva nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: If the patient cannot switch to the twice-daily dose within four weeks of starting Nevirapine Teva, alternative treatments should be sought.
Croatian: Ako bolesnik ne može prijeći na dozu dva puta dnevno u roku od četiri tjedna nakon početka terapije lijekom Nevirapine Teva, potrebno je razmotriti alternativna liječenja.
English: Two medicines are bioequivalent when they produce the same levels of the active substance in the body.
Croatian: Dva lijeka su bioekvivalentna kada u tijelu proizvode iste razine djelatne tvari
English: Nevirapine Teva nevirapine
Croatian: Nevirapine Teva nevirapin
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Nevirapine Teva.
Croatian: Objašnjava kako je Odbor za lijekove za humanu uporabu (CHMP) ocijenilo lijek da bi donio svoje mišljenje u korist davanja odobrenja za stavljanje lijeka u promet i svoje preporuke o uvjetima za primjenu lijeka Nevirapine Teva.
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom increased to the full twice-daily dose until any rash has cleared.
Croatian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
English: Nevirapine Teva does not cure HIV-1 infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.
Croatian: Nevirapine Teva ne liječi infekciju virusom HIV-1 ili AIDS, no može odgoditi oštećenje imunosnog sustava i razvoj infekcija te bolesti povezanih sa AIDS-om.
English: It is used in combination with other antiviral medicines to treat patients infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS).
Croatian: Koristi se u kombinaciji s drugim lijekovima za liječenje bolesnika inficiranih virusom humane imunodeficijencije tipa 1 (HIV-1), virusom koji uzrokuje sindrom stečene imunodeficijencije (AIDS).
English: This means that Nevirapine Teva is similar to a ‘reference medicine' already authorised in the European Union (EU) called Viramune.
Croatian: To znači da je Nevirapine Teva sličan „referentnom lijeku” koji je već odobren u Europskoj uniji pod nazivom Viramune.
English: For more information about treatment with Nevirapine Teva, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Nevirapine Teva pročitajte u uputi lijeka (također dio EPAR-a), odnosno obratite se svom liječniku ili ljekarniku.
English: The European Commission granted a marketing authorisation valid throughout the EU for Nevirapine Teva on 30 November 2009.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje za lijek Nevirapine Teva vrijedi na prostoru Europske unije od 30. studenog 2009.
English: By blocking this enzyme, Nevirapine Teva, taken in combination with other antiviral medicines, reduces the amount of HIV-1 in the blood and keeps it at a low level.
Croatian: Inhibirajući ovaj enzim, Nevirapine Teva, ako se uzima u kombinaciji s drugim antiviroticima, smanjuje količinu virusa HIV-1 u krvi i pomaže pri održavanju niske razine.
English: This is a summary of the European public assessment report (EPAR) for Nevirapine Teva.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Nevirapine Teva.
English: What are the benefits and risks of Nevirapine Teva?
Croatian: Koje su koristi i rizici lijeka Nevirapine Teva?
English: It blocks the activity of reverse transcriptase, an enzyme produced by HIV-1 that allows it to infect cells in the body and make more viruses.
Croatian: Inhibira djelovanje reverzne transkriptaze, enzima kojeg proizvodi HIV-1 koji omogućuje virusu inficiranje stanica u tijelu i proizvodnju većih količina virusa.
English: Treatment with Nevirapine Teva should be given by a doctor who has experience in the treatment of HIV infection.
Croatian: Liječenje Nevirapine Teva moraju primjenjivati liječnici s iskustvom u liječenju infekcije HIV-om.
English: Because Nevirapine Teva is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine.
Croatian: Budući da je Nevirapine Teva generički lijek te je bioekvivalent referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
English: The CHMP concluded that, in accordance with EU requirements, Nevirapine Teva has been shown to have comparable quality and to be bioequivalent to Viramune.
Croatian: CHMP je zaključio kako je, u skladu sa zahtjevima EU-a, potvrđeno kako Nevirapine Teva posjeduje usporedivu kvalitetu te je bioekvivalentan referentnom lijeku Viramune.
English: Nevirapine Teva is a ‘generic medicine'.
Croatian: Nevirapine Teva je „generički lijek”.
English: The active substance in Nevirapine Teva, nevirapine, is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Croatian: Djelatna tvar lijeka Nevirapine Teva, nevirapin, je nenukleozidni inhibitor reverzne transkriptaze (NNRTI).
English: Other information about Nevirapine Teva
Croatian: Ostale informacije o lijeku Nevirapine Teva
English: Nevirapine Teva is an antiviral medicine.
Croatian: Nevirapine Teva je antivirotik.
English: Because Nevirapine Teva is a generic medicine, studies have been limited to tests to determine that it is bioequivalent to the reference medicine, Viramune.
Croatian: Budući da je Nevirapine Teva generički lijek, ispitivanja na bolesnicima bile su ograničena na utvrđivanje činjenice je li riječ o bioekvivalentu referentnom lijeku Viramune.
English: Nevirapine Teva is a medicine that contains the active substance nevirapine.
Croatian: Nevirapine Teva je lijek koji sadrži djelatnu tvar nevirapin.
English: What is Nevirapine Teva?
Croatian: Što je Nevirapine Teva?
English: The Committee recommended that Nevirapine Teva be given marketing authorisation.
Croatian: Odbor je preporučio izdavanje odobrenja za stavljanje u promet lijeka Nevirapine Teva u EU-u.
English: Why has Nevirapine Teva been approved?
Croatian: Zašto je lijek Nevirapine Teva odobren?
English: Nevirapine Teva is never taken on its own.
Croatian: Nevirapine Teva se nikada ne primjenjuje kao monoterapija.
English: Therefore, the CHMP's view was that, as for Viramune, the benefit outweighs the identified risk.
Croatian: Stoga je stav CHMP-a kako koristi nadmašuju utvrđene rizike, kao i kod lijeka Viramune.
English: What is Nevirapine Teva used for?
Croatian: Za što se Nevirapine Teva koristi?
English: How is Nevirapine Teva used?
Croatian: Kako se Nevirapine Teva koristi?
English: How has Nevirapine Teva been studied?
Croatian: Kako je Nevirapine Teva ispitivan?
English: How does Nevirapine Teva work?
Croatian: Kako djeluje Nevirapine Teva?
English: Can't be sold separately.
Croatian: Ne može se prodavati odvojeno.
English: Date of latest renewal: 24.05.2017
Croatian: Datum posljednje obnove odobrenja: 24.05.2017
English: - Low counts of white blood cells and blood platelets.
Croatian: Nizak broj bijelih krvnih stanica i krvnih pločica
English: If any of these apply to you, tell your doctor straight away.
Croatian: Ako Vam se dogodi bilo što od navedenog, odmah se javite liječniku.
English: - Storage conditions of the diluted solution are described in the above paragraph (See “How to prepare and administer Zoledronic acid Mylan”).
Croatian: - Uvjeti čuvanja razrijeđene otopine opisani su u gornjem odlomku (vidjeti “Kako pripremiti i primijeniti Zoledronatnu kiselinu Mylan”).
English: Zoledronic acid Mylan can be given to people aged 65 years and over.
Croatian: Zoledronatna kiselina Mylan može se davati osobama u dobi od 65 ili više godina.
English: In some instances the hypocalcaemia may be life-threatening.
Croatian: U nekim slučajevima hipokalcemija može ugroziti život.
English: - Interstitial lung disease (inflammation of the tissue around the air sacks of the lungs).
Croatian: - Intersticijska plućna bolest (upala tkiva oko zračnih vrećica pluća).
English: - Talk to your doctor if you have ear pain, discharge from the ear, and/or an ear infection.
Croatian: - Obratite se liječniku ako imate bol u uhu, iscjedak iz uha i/ili infekciju uha.
English: Other medicines and Zoledronic acid Mylan Tell your doctor if you are taking, have recently taken or might take any other medicines.
Croatian: Drugi lijekovi i Zoledronatna kiselina Mylan Obavijestite svog liječnika ako uzimate, nedavno ste uzeli ili biste mogli uzeti bilo koje druge lijekove.
English: Healthcare professionals are advised not to dispose of unused Zoledronic acid Mylan via the domestic sewage system.
Croatian: Zdravstvenim radnicima se savjetuje da ne uklanjaju neiskorištenu Zoledronatnu kiselinu Mylan putem kućnog odvodnog sustava.
English: - A kidney function disorder called Fanconi syndrome (will normally be determined by your doctor with certain urine tests).
Croatian: - Poremećaj rada bubrega koji se zove Fanconijev sindrom (kojeg inače može odrediti Vaš liječnik pomoću određenih testova urina).
English: Pam 90 mg
Croatian: Pamidronat 90 mg
English: In some instances, the hypocalcaemia may be life-threatening (see section 4.8).
Croatian: U nekim slučajevima hipokalcemija može ugroziti život (vidjeti dio 4.8).
English: - If you have a kidney problem, your doctor will give you a lower dose depending on the severity of your kidney problem.
Croatian: - Ako imate tegobe s bubrezima, liječnik će Vam dati nižu dozu ovisno o težini tegoba koje imate s bubrezima.
English: Ask your doctor for advice before taking any medicine while you are pregnant or breast-feeding.
Croatian: Obratite se svom liječniku za savjet prije nego što uzmete ovaj lijek ako ste trudni ili dojite.
English: - Keep Zoledronic acid Mylan out of the sight and reach of children.
Croatian: - Zoledronatnu kiselinu Mylan čuvajte izvan pogleda i dohvata djece.
English: If a lower dose of Zoledronic acid Mylan is required, first withdraw the appropriate volume as indicated below and then dilute it further with 100 ml of infusion solution.
Croatian: Ako je potrebna niža doza Zoledronatne kiseline Mylan, prvo izvucite odgovarajući volumen kako je navedeno niže, i potom ga dodatno razrijedite sa 100 ml otopine za infuziju.
English: - Concomitant therapies: chemotherapy, angiogenesis inhibitors (see section 4.5), radiotherapy to neck and head, corticosteroids.
Croatian: - Istodobna terapija: kemoterapija, inhibitori angiogeneze (vidjeti dio 4.5), radioterapija vrata i glave, kortikosteroidi.
English: While being treated with Zoledronic acid Mylan, you should maintain good oral hygiene (including regular teeth brushing) and receive routine dental check-ups.
Croatian: Za vrijeme liječenja Zoledronatnom kiselinom Mylan, morate održavati dobru oralnu higijenu (uključujući redovito pranje zuba) i obavljati rutinske preglede kod zubara.
English: - To reduce the amount of calcium in the blood in adult patients where it is too high due to the presence of a tumour.
Croatian: - smanjenje količine kalcija u krvi u odraslih bolesnika kad je količina kalcija prevelika zbog prisutnosti tumora.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 23.08.2012
Croatian: Datum prvog odobrenja: 23.08.2012.
English: MYLAN PHARMACEUTICALS Sp. z o.o.
Croatian: MYLAN PHARMACEUTICALS Sp. z o.o. ul.
English: Zoledronic acid Mylan is not recommended for use in adolescents and children below the age of 18 years.
Croatian: Ne preporučuje se primjena Zoledronatne kiseline Mylan u adolescenata i djece mlađe od 18 godina.
English: 117 allée des Parcs 69800 SAINT-PRIEST France
Croatian: 117 allée des Parcs 69800 SAINT-PRIEST FRANCUSKA
English: Each vial contains 5 ml of concentrate.
Croatian: Svaka bočica sadrži 5 ml koncentrata.
English: Zoledronic acid Mylan is supplied as packs containing 1, 4 or 10 vials or as multipacks comprising 4 packs, each containing 1 vial.
Croatian: Zoledronatna kiselina Mylan se isporučuje u pakiranjima koja sadrže 1, 4 ili 10 bočica ili kao višestruko pakiranje koje sadrži 4 pakiranja od kojih svako sadrži 1 bočicu.